SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-054943
Filing Date
2021-04-26
Accepted
2021-04-26 16:34:16
Documents
14
Period of Report
2021-04-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2114106d1_8k.htm   iXBRL 8-K 26409
2 EXHIBIT 99.1 tm2114106d1_ex99-1.htm EX-99.1 12982
6 GRAPHIC tm2114106d1_ex99-1image001.jpg GRAPHIC 12340
  Complete submission text file 0001104659-21-054943.txt   233446

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA qure-20210423.xsd EX-101.SCH 3184
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE qure-20210423_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qure-20210423_pre.xml EX-101.PRE 22709
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2114106d1_8k_htm.xml XML 3498
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36294 | Film No.: 21854312
SIC: 2834 Pharmaceutical Preparations